Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 11, 2000, Pages 3092-3096

  Ma, L ^a   Kovacs, J A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; FOLIC ACID ANTAGONIST; METHOTREXATE; PYRIMETHAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRIMETHOPRIM; TRIMETREXATE;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG POTENCY; DRUG SELECTIVITY; ENZYME ANALYSIS; ENZYME KINETICS; ENZYME PURIFICATION; ESCHERICHIA COLI; GENE SEQUENCE; HUMAN; NONHUMAN; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BINDING, COMPETITIVE; CATALYSIS; ESCHERICHIA COLI; FOLIC ACID ANTAGONISTS; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; TETRAHYDROFOLATE DEHYDROGENASE; TRANSFECTION;

EID: 0033752816     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.11.3092-3096.2000     Document Type: Article

References (27)

1. Trimetrexate for the treatment of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome
2. Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent
3. Dihydrofolate reductase hysteresis and its effect of inhibitor binding analyses
4. Eukaryotic dihydrofolate reductase
5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Pneumocystis carinii dihydrofolate reductase used to screen potential antipneumocystis drugs
7. Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme
8. Isolation and expression of the Pneumocystis carinii dihydrofolate reductase gene
9. Studies on plant amylases. I. The effect of starch concentration upon the velocity of hydrolysis by the amylase of germinated barley
10. Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia
11. Steady-state enzyme kinetics with high-affinity substrates or inhibitors. A statistical treatment of dose-response curves
12. Effect of substrate decomposition on the spectrophotometric assay of dihydrofolate reductase
13. Construction of defined deletion mutants by thermal cycled fusion: Applications to protein kinase C
14. Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in AIDS patients
15. Combination of pentamidine and trimethoprim-sulfamethoxazole in therapy of Pneumocystis carinii pneumonia in rats
16. Characterization of de novo folate synthesis in Pneumocystis carinii and Toxoplasma gondii: Potential for screening therapeutic agents
17. Characterization of dihydrofolate reductase of Pneumocystis carinii and Toxoplasma gondii
18. Pneumocystis carinii pneumonia: Therapy and prophylaxis
19. Recombinant carboxyltransferase responsive to redox of pea plastidic acetyl-CoA carboxylase
20. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use
21. Dihydrofolate reductase from the pathogenic fungus Pneumocystis carinii: Catalytic properties and interaction with antifolates
22. Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection
23. Kinetic characterization of dihydrofolate reductase from Drosophila melanogaster
24. Purification and properties of recombinant Pneumocystis carinii dihydrofolate reductase
25. Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia
26. Molecular characterisation of Trypanosoma brucei alkyl dihydroxyacetone-phosphate synthase